Nanostring Technologies Inc Stock Ownership - Who owns Nanostring Technologies?

Insider buying vs selling

Have Nanostring Technologies Inc insiders been buying or selling?
William 1. YoungDirector2023-05-2435,400$5.69
Gregory NordenDirector2023-04-278,768$8.45
Charles P. Waite Jr.Director2023-03-1312,000$8.35
Gregory NordenDirector2023-03-0712,500$9.84
Joseph M. BeechemSVP Research Development2023-03-063,996$10.16
Joseph M. BeechemSVP Research Development2023-03-061,423$10.16
Joseph M. BeechemSVP Research Development2023-03-061,979$10.16
R. Bradley GrayPresident and CEO2023-03-0610,357$10.16
K. Thomas BaileyChief Financial Officer2023-03-063,321$10.16
K. Thomas BaileyChief Financial Officer2023-03-061,063$10.16

1 of 3

NSTG insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NSTG insiders and whales buy or sell their stock.

NSTG Shareholders

What type of owners hold Nanostring Technologies Inc stock?
Clarus Lifesciences Ii LP12.83%6,072,050$35.10MInsider
Wellington Management Group LLP10.39%4,916,409$28.42MInstitution
Blackrock Inc10.06%4,759,506$27.51MInstitution
Nicholas Galakatos8.53%4,036,025$23.33MInsider
Blackstone Holdings Ii LP8.53%4,036,025$23.33MInsider
Polar Capital Holdings PLC8.45%4,000,000$23.12MInstitution
Finny Kuruvilla8.36%3,959,440$22.89MInsider
Ovp Venture Partners Vi LP7.14%3,378,830$19.53MInsider
Vanguard Group Inc5.38%2,547,123$14.72MInstitution
Ra Capital Management LP5.19%2,457,273$14.20MInstitution

1 of 3

NSTG vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NSTG63.27%36.73%Net BuyingNet Buying
GBIO65.80%34.20%Net SellingNet Selling
ACRV50.66%49.34%Net Buying
RPHM50.77%47.82%Net BuyingNet Buying
CRBU73.15%12.39%Net BuyingNet Buying

Nanostring Technologies Stock Ownership FAQ

Who owns Nanostring Technologies?

Nanostring Technologies (NASDAQ: NSTG) is owned by 98.00% institutional shareholders, 56.88% Nanostring Technologies insiders, and 0.00% retail investors. Clarus Lifesciences Ii LP is the largest individual Nanostring Technologies shareholder, owning 6.07M shares representing 12.83% of the company. Clarus Lifesciences Ii LP's Nanostring Technologies shares are currently valued at $35.10M.

If you're new to stock investing, here's how to buy Nanostring Technologies stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.